Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
CDER Town Hall: Part 1 of 2
Track : Track 18: Global Regulatory
Program Code: 417
Date: Thursday, June 27, 2013
Time: 9:00 AM to 10:30 AM  EST
Location: 210B
CHAIR :
 Nancy D. Smith, PhD (SCHNON), Independent Consultor, United States
SPEAKER (S):
 Gerald J. Dal Pan, MD (SPKAGY), Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
 John K. Jenkins, MD (SPKAGY), Director, Office of New Drugs, CDER, FDA, United States
 Robert T. O'Neill, PhD (SPKAGY), Senior Statistical Advisor, Office of Translational Sciences, CDER, FDA, United States
 Robert J. Temple, MD (SCHAGY), Deputy Center Director for Clinical Science, CDER, FDA, United States
 Justina A. Molzon, JD,MPharm (SPKAGY), Associate Center Director for International Programs, CDER, FDA, United States
Description
This forum is a roundtable discussion with CDER leadership. Topics to be discussed will depend on the interests of the audience. Panel members will discuss and update regulatory changes and the current hot topics at CDER.

Part 2 of this forum will take place Thursday, June 27 at 10:45 am

Session Recording
(Code: 417)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON5 Comp Access: Thursday Online Access Package - June 27, 2013
Handout Online
(Code: 417)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON5 Comp Access: Thursday Online Access Package - June 27, 2013
CDER Town Hall: Part 1 of 2